// App-Quantinova.ai

: Real-World Evidence of Collecting Quality of Life (QoL) and Symptoms Perception Using the HM-PRO© Tool As a Patient-Reported Outcome Measure (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy

Researchers

Presenter

  • Lucia Castilla Garcia

Principal Investigators

  • Alberto Lopez García

  • Natalia Barreras Ruiz

  • Eva Castillo Bazan

  • Adriana Pascual

  • Miriam Riesco Ovelar

  • Celia Urrutia

  • Susana Cruz

  • Alberto Pardo

  • Antonio Herrero

  • Maria Angeles Perez Saenz

  • Daniel Morillo Gilles

  • Maria Pilar Llamas Sillero

  • JAVIER BECARES

  • CARLA BARRIOCANAL

  • Jorge Short Apellaniz

  • Marta del Olmo

  • Javier Arcos Campillo

  • Raul Cordoba

Medical Centers

  • Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain

  • Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain

  • Fundacion Jimenez Diaz University Hospital, Madrid, Spain

  • Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain

  • Haematology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, ESP

  • Information and Communication technology (ICT) department., Fundación Jimenez Díaz University Hospital, Madrid, Spain

  • Clinical and Organizational Innovation Unit (UICO); QUIRONSALUD PUBLIC HOSPITALS NETWORK, Madrid, Spain

  • Oncohealth Institute, Fundacion Jimenez Diaz University Hospital, Madrid, Spain

  • Department of Hematology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Obstetrics/Gynecology

Disease

  • Lymphomas

  • Preterm premature rupture of the membranes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved